0001567619-20-008036.txt : 20200416
0001567619-20-008036.hdr.sgml : 20200416
20200416161206
ACCESSION NUMBER: 0001567619-20-008036
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200414
FILED AS OF DATE: 20200416
DATE AS OF CHANGE: 20200416
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ALBRECHT DETLEF
CENTRAL INDEX KEY: 0001286642
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39041
FILM NUMBER: 20796541
MAIL ADDRESS:
STREET 1: SATSUMA PHARMACEUTICALS, INC.
STREET 2: 400 OYSTER POINT BOULEVARD, SUITE 221
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Satsuma Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001692830
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813039831
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 OYSTER POINT BOULEVARD
STREET 2: SUITE 221
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 64080
BUSINESS PHONE: 415-505-0809
MAIL ADDRESS:
STREET 1: 400 OYSTER POINT BOULEVARD
STREET 2: SUITE 221
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 64080
4
1
doc1.xml
FORM 4
X0306
4
2020-04-14
0
0001692830
Satsuma Pharmaceuticals, Inc.
STSA
0001286642
ALBRECHT DETLEF
C/O SATSUMA PHARMACEUTICALS, INC.
400 OYSTER POINT BOULEVARD, SUITE 221
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Medical Officer
Common Stock
2020-04-14
4
M
0
800
4.56
A
20812
D
Common Stock
2020-04-14
4
S
0
800
20.00
D
20012
D
Stock Option (Right to Buy)
4.56
2020-04-14
4
S
0
800
0
D
2029-05-16
Common Stock
800
72468
D
Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
The option vest and become exercisable in successive, equal monthly installments over four years measured from May 15, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
/s/ Thomas P. O'Neil as Attorney in Fact for Detlef Albrecht, M.D.
2020-04-16